Trial intelligence / Profile preview

ANTERO-1: VIPUN Balloon Catheter Evaluation

NCT03239821Completed

Sponsor
UZ Leuven
Start
Sep 2017
Primary completion
Mar 2018
Countries
1
01

Overview

Randomised, double-blind trial (4 arms), sponsored by UZ Leuven. Primary endpoints: Incidence, frequency, severity, seriousness and relatedness of Adverse Events at 8 hours, Success rate in completing the procedure (placement and removal VIPUN Balloon Catheter) at 8 hours and 1 more. Started Sep 2017; status: completed.

Beyond the preview

Go deeper on NCT03239821.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03239821.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call